Therefore, APP expression, which plays a role in cholesterol turnover [28], may be linked to lipid homeostasis, but its expression level may not be causative for Aβ-42 tissue concentration in the livers of patients with MASLD. Here, APP is linked to metabolic dysfunction-associated steatotic liver disease.